MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on October 4, 2006; DOI: 10.1124/mol.106.026575


0026-895X/07/7101-61-72$20.00
Mol Pharmacol 71:61-72, 2007

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.106.026575v1
71/1/61    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kamath, R.
Right arrow Articles by Baskaran, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kamath, R.
Right arrow Articles by Baskaran, R.

c-Abl Kinase Regulates Curcumin-Induced Cell Death through Activation of c-Jun N-Terminal Kinase

Ravindra Kamath, Zhihua Jiang, Guoming Sun, Jack C. Yalowich, and R. Baskaran

Departments of Molecular Genetics and Biochemistry (R.K., Z.J., R.B) and Pharmacology (J.C.Y), University of Pittsburgh, School of Medicine, Pittsburgh, Pennsylvania

Curcumin, a natural phenolic compound found in turmeric (Curcuma longa) exhibits anticancer properties, attributed to its antiproliferative and apoptosis-inducing activity. The ubiquitously expressed nonreceptor tyrosine kinase c-Abl regulates stress responses induced by oxidative agents such as ionizing radiation and H2O2. In this study, we show that c-Abl is an important component of the cell death response activated by curcumin and that Abl mediates this response partly through activation of c-Jun N-terminal kinase (JNK). Therefore, inhibition of Abl by STI571 [imatinib (Gleevec)] treatment or down-regulation of Abl expression through Abl-specific short-hairpin RNA (shRNA) diminished cell death induction and JNK activation. Highlighting the interdependent nature of the Abl and JNK signaling in the curcumin-induced cell death response, a JNK inhibitor [anthra(1,9-cd)pyrazol-6(2H)-one-1,9-pyrazoloanthrone (SP600125)] caused very little cell death inhibition in STI571-pretreated cells and in Abl shRNA-expressing cells. Moreover, treatment with Abl and JNK inhibitor alone or together caused similar levels of cell death inhibition. Although p53 induction in response to curcumin treatment is dependent on Abl, we found that Abl->p53 signaling is not necessary for curcumin-induced cell death. Taken together, the results demonstrate the differential roles played by Abl->p53 and Abl->JNK signaling events in modulating the cell death response to curcumin.


Received for publication May 11, 2006.

Accepted for publication October 3, 2006.

Address correspondence to: Baskaran Rajasekaran, University of Pittsburgh School of Medicine, Department of Molecular Genetics and Biochemistry, E1205 Biomedical Science Tower, Pittsburgh, PA 15261. E-mail: bask{at}pitt.edu




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. W. Wagner, L. S. Li, J. C. Morales, C. L. Galindo, H. R. Garner, W. G. Bornmann, and D. A. Boothman
Role of c-Abl Kinase in DNA Mismatch Repair-dependent G2 Cell Cycle Checkpoint Arrest Responses
J. Biol. Chem., August 1, 2008; 283(31): 21382 - 21393.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics